DCLK1 and breast cancer: DCLK1 in BC regulates the regulating Wnt/β-catenin signaling pathway, and in presence of Wnt/β-catenin pathway inhibitor (Wnt/β-catenin-IN-1), the cells’ proliferation is lowered (Wang et al., 2019c; Liu et al., 2019).